Posts Tagged ‘Body Mass Index’

The BMI Pit

June 12th, 2013

Arya Sharma has an excellent post today on an article detailing the weakness of using the Body Mass Index in clinical practice. Readers of the Downey Obesity Report will be familiar with some of the criticism. In addition to its weakness as a clinical tool, the BMI has even greater, in my opinion, weaknesses in the policy arena as it is used by the Food and Drug Administration to classify appropriate usage of drugs and medical devices, in the reimbursement arena or in the recent fight over employer wellness plans.

 

More bad news for the BMI

September 26th, 2012

Nirav Shah of NYU School of Medicine and Eric Braverman of Weill-Cornell Medical College have published more evidence on the limitations of the Body Mass Index (BMI). Their study looked at adults according to BMI, DXA, fasting leptin and insulin. 39% of the subjects were found to be obese by DXA (which is a direct measurement of body fat) but not by BMI. BMI misclassified 25% of the men and 48% of the women. A strong relationship was found between increased leptin levels and increased body fat. Women demonstrated a clear correlation between advancing age and increasing miscalculation, with over half misclassified by age 60-69. This association was not apparent for men.

The authors state, “BMI significantly underestimates adiposity. A better cutpoint for obesity with BMI is 24 for females and 28 for males. ..Obesity, body fat and increased adiposity are more prevalent than the American public and American physicians are aware of. This is contributing greatly to multiple co-morbidities such as hyperlipidemia, coronary artery disease, hypertension, and diabetes. The current systematic underestimation of adiposity in large scale studies, and subsequent use of such studies for public health policy-making, can readily be corrected, resulting in a more appropriate sense of urgency and more cogent weighing of public health priorities.” PubMed: Measuring Adiposity in Patients

 

Improvements Seen in Obesity Reimbursement

May 13th, 2012

A Washington Post article by Judith Graham points out the progress made in getting insurers and physicians to screen patients for obesity and reimburse for counseling and treatment. I can add that at one of the recent FDA Advisory Committee meetings, an FDA health officer presented data indicating that about half of prescription drugs for obesity were paid for by insurance plans now. WaPo: BMI as vital sign

In addition, conversations with health plan representatives indicate that they are getting more requests from employers for riders covering obesity interventions, including bariatric surgery. These are considerable improvements from a few years ago.